Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Phase 2 Results for Nano-formulated NSAIDs under Development at Iroko Pharmaceuticals to Be Reported at ACR Meeting

Abstract:
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology (ACR) in Chicago.

Phase 2 Results for Nano-formulated NSAIDs under Development at Iroko Pharmaceuticals to Be Reported at ACR Meeting

Philadelphia, PA | Posted on November 4th, 2011

The data result from a broad development effort using a proprietary nanotechnology to re-formulate certain products in the large class of pain medicines called NSAIDs (non-steroidal anti-inflammatory drugs). Nano-formulations reduce drug particle size and enhance drug dissolution in the body.

The objective is to lower the dosing of NSAIDs and thus improve their safety and tolerability while maintaining their effectiveness. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) both have advised that NSAIDs should be administered at the lowest effective dose for the shortest duration consistent with treatment goals.1,2

Iroko has initiated its Phase 3 program.

At the ACR meeting, the Phase 2 results will be the subject of three presentations:

Application of Nanotechnology to Improve Non-Steroidal Anti-Inflammatory Drugs
(Presentation Number: 1282)
A Phase 2 Study Evaluating the Acute Pain Relief of a Nano-Formulated Oral Naproxen
(Presentation Number: 1281)
Acute Pain Relief by a Proprietary, Nano-Formulated Lower-Dose Oral Indomethacin
(Presentation Number: 1280)

The presentations will be made on November 7th from 9:00-11:00 AM in the F2 Poster Hall at the McCormick Place Convention Center.

Nano-formulations
Iroko formulates NSAIDs using the proprietary SoluMatrix™ nanotechnology platform of its partner, iCeutica. These product candidates are intended for administration at lower doses without compromising onset of action and effectiveness, in keeping with the public-health advisories of the FDA and the EMA.

####

About Iroko Pharmaceuticals, LLC
Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global basis through focused selling and marketing efforts and product-life-cycle management activities including development of new formulations to improve patient treatment.

1Public Health Advisory – FDA Announces Important Changes and Additional Warnings for COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDS). July 7, 2005.

2Opinion of the Committee for Medicinal Products for Human Use Pursuant to Article 5(3) of Regulation (EC) No 726/2004, for Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDS). October 18, 2006.

For more information, please click here

Contacts:
Phoenix IP Ventures
Lisa Gray
Managing Partner
267-765-3233

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Who needs water to assemble DNA? Non-aqueous solvent supports DNA nanotechnology May 27th, 2015

Controlled Release of Anticorrosive Materials in Spot by Nanocarriers May 27th, 2015

Production of Copper Cobaltite Nanocomposites with Photocatalytic Properties in Iran May 27th, 2015

Dr.Theivasanthi Slashes the Price of Graphene Heavily: World first & lowest price – Nano-price (30 USD / kg) of graphene by nanotechnologist May 26th, 2015

Nanomedicine

Who needs water to assemble DNA? Non-aqueous solvent supports DNA nanotechnology May 27th, 2015

DNA Double Helix Does Double Duty in Assembling Arrays of Nanoparticles: Synthetic pieces of biological molecule form framework and glue for making nanoparticle clusters and arrays May 25th, 2015

Nanostructures Increase Corrosion Resistance in Metallic Body Implants May 24th, 2015

Iranian Scientists Use Magnetic Field to Transfer Anticancer Drug to Tumor Tissue May 24th, 2015

Announcements

Who needs water to assemble DNA? Non-aqueous solvent supports DNA nanotechnology May 27th, 2015

Controlled Release of Anticorrosive Materials in Spot by Nanocarriers May 27th, 2015

Production of Copper Cobaltite Nanocomposites with Photocatalytic Properties in Iran May 27th, 2015

Dr.Theivasanthi Slashes the Price of Graphene Heavily: World first & lowest price – Nano-price (30 USD / kg) of graphene by nanotechnologist May 26th, 2015

Events/Classes

Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015

Aspen Aerogels to Present at the Cowen and Company Technology, Media & Telecom Conference May 21st, 2015

Directa Plus in Barcelona to present the innovative project GEnIuS for oil spills clean-up activities: The company has created a graphene-based product for the remediation of water contaminated by oil and hydrocarbons May 21st, 2015

Nanometrics Announces Live Webcast of Upcoming Investor and Analyst Day May 20th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project